Navigation Links
Bavarian Nordic A/S - Interim Report for the Period 1 January to 30 June 2008
Date:8/19/2008

KVISTGARD, Denmark, August 19 /PRNewswire-FirstCall/ -- Today Bavarian Nordic published the company's interim report as of 30 June 2008. The full financial statements are available on the company's website. Below is an extract of the most significant matters in the report as well as events after the balance sheet date.

In the first half of 2008 Bavarian Nordic generated revenue of DKK 23 million and recorded a loss before tax of DKK 119 million. The expectations for the financial result for the full year 2008 are maintained at revenues in the level of DKK 180 million, and a pre-tax loss in the level of DKK 225 million. The main part of the revenue comprises of a milestone payment under the RFP-3 contract, which is expected in the fourth quarter of 2008. As of 30 June 2008 the Group's net free liquidity was DKK 882 million. The Company raises its expectations for the net free liquidity at year-end 2008 from approx. DKK 500 million to approx. DKK 620 milllion. The increase comprises of DKK 80 million from released trusted funds and DKK 40 million from realised fair value of forward rate agreements.

Highlights

- Bavarian Nordic partners with the National Cancer Institute in the US

In August, Bavarian Nordic entered into a scientific partnership with the National Cancer Institute. NCI and Bavarian Nordic will jointly develop new immunotherapies for the treatment of prostate cancer. Through the collaboration, the company has obtained rights to intellectual property rights covering a prostate cancer vaccine product candidate in late phase II clinical development.

- Bavarian Nordic has signed contract with Asian country for the delivery

of IMVAMUNE(R)

Bavarian Nordic has signed a three-year contract with the government of an Asian country for the delivery of a small order of IMVAMUNE(R) for the country's biodefense programme.

- More than 1,900 subjects now vaccinated with IMVAMUNE(R)

To-date, mor
'/>"/>

SOURCE Bavarian Nordic A/S
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process
2. Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones
3. LPBP Inc. - Re-filing certification of interim filings
4. Fufeng Announces 2008 Interim Results With Strong Sign of Recovery
5. BioMS Medical announces positive interim analysis on phase III trial of dirucotide (MBP8298) for multiple sclerosis
6. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
7. Quest PharmaTech Announces Interim Results from Phase I/II Clinical Trial for Photodynamic Treatment for Hair Removal
8. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
9. Clarification on Press Release Issued Earlier Today: Targeted Genetics Confirms Positive, Interim Phase 1/2 Study Findings
10. Steve Davis Joins Infectious Disease Research Institute (IDRI) as Interim CEO
11. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Combination REOLYSIN(R) and Carboplatin/Paclitaxel Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... -- DSM Pharmaceutical Products today announced th...ix, Saint Jean D,Illac, France, where DSM will be ...er for Galenix commercial products on a global bas...ness development opportunities co-marketing Galeni...h of Galenix in drug product development and clini...
(Date:11/5/2009)...swire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: ...for processing and storing adult stem cells, today...2010. ,, For the quarter ended September 30, 20... a 15 percent increase over revenues of $4.5 milli...id the key contributors to the growth in revenues ...
(Date:11/5/2009)...Call/ -- Transgenomic, Inc. (OTC Bulletin Board: T...rter ended September 30, 2009. The Company,s finan...ow. ,, Third Quarter 2009 ,, The Company r...for the third quarter of 2009 as compared to a net... quarter of 2008. ,, Net sales were $5.0 milli...
(Date:11/5/2009)...-FirstCall/ -- Cepheid (Nasdaq: CPHD ) today anno...following investor conferences, and invited invest... Credit Suisse Healthcare Conference, Phoenix, AZ...0 a.m. Mountain Time, NASDAQ OMX ... Tuesday, 1 December, 2009 at 10.45 a.m. Gree...
Breaking Biology Technology:DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7Cepheid to Webcast Upcoming Financial Presentations 2
...rd Wave Technologies this week reported the best ...story, wrapping up a year in which it met or excee...d Wave reported total revenues of $46.5 million an...cember 31, compared to total revenues of $36.3 mil...The company reported total revenues of $8.1 millio...
...r community when power stands still? , ,A. Things... wag; its always someone elses fault. , ,C. Young...wn initiative. , ,If you answered "C," you might ...r for the first time in our companys seven year hi.... Unwilling to wait for their communitys tradition...
...usiness. Whoa! Put down those pitchforks and torc...start some kind of technology for technology,s sak... people who are in the business of building and se...er, in the last twenty or so years as wave after w...orld, it became easy, accepted and even fashionabl...
Other Biology Technology:Third Wave boosts numbers in latest report 2Third Wave boosts numbers in latest report 3Third Wave boosts numbers in latest report 4Lead, follow or get out of the way 2Stay in the driver's seat, but don't ditch technology 2Stay in the driver's seat, but don't ditch technology 3
(Date:11/8/2009)...earchers at Purdue University have discovered a ne...pinal cord injuries using nano-spheres that could ...nt. , The synthetic "copolymer micelles" are dru..., or roughly 100 times smaller than the diameter o...ying how to deliver drugs for cancer treatment and...
(Date:11/8/2009)... FOR ADULTS WITH INTELLECTUAL DISABILITIES: AN OPP...rsity study involving adults with intellectual dis...rsonal health knowledge after taking a semi-weekly...ernationally accepted term for mental retardation,...nactivity and preventable chronic diseases compare...
(Date:11/6/2009)...rsary this month of the publication of On the Orig...l Sciences (AIBS) is publishing open access two pe...historic insights into evolution. , The two artic...ornia, Berkeley, and James T. Costa of Western Car...ut Charles Darwin," appeared in the October issue ...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 2Indiana U. at APHA: Studies about health education for people with ID, stability balls at work 3Many Childhood Cancer Survivors Never Marry 59131 1Many Childhood Cancer Survivors Never Marry 59131 2Swine Flu 28H1N1 29 Virus Destroyed by Innovative Air Treatment Technology 59127 1Swine Flu 28H1N1 29 Virus Destroyed by Innovative Air Treatment Technology 59127 2ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 1ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 2ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 3ABAXIS Announces Launch of the First Fully Automated Canine Wellness Profile That Includes a Canine Heartworm Antigen Test 5321 4
...ientists has used gene therapy in two separate stu...ents in monkeys and rats with a drug-induced form ...online in the scientific publications Brain and Th...ne strategy to halt Parkinson,s disease at its ons...ide effects that occur when treating the disease i...
... reveal how an,evolutionary innovation involving t...ven rise to a deep-seated dependency between them ...new work illustrates how genetic exchange through ... a system of interdependence at a,high level of bi...on of,worker ants for both species. , Millions,of ...
...he journal Nature that the "missing" genes for tRN...ogether sequences in distant parts of the DNA geno...n the Department of Molecular Biophysics and Bioch...sm with a known genome sequence. Nanoarchaeum equi... the Archaea containing organisms that are primiti...
Other Biology News:Gene Therapy For Parkinson's Disease Moves Forward In Animals 2Gene Therapy For Parkinson's Disease Moves Forward In Animals 3Gene Therapy For Parkinson's Disease Moves Forward In Animals 4Ants Genetic Engineering Leads To Species Interdependency 2Researchers find missing genes of ancient organism 2
...rs combine high durability and capacity with unequ...nced heavy-duty mechanism prevents vibration, allo...alance loads. Every other part, from the large rub...chined aluminum platform is designed to last throu...
RapidStak 2 (requires 4 staks, not included) from Thermo Scientific
Small bottle, 150 x 35mm from Thermo Scientific
Extra large bottle, 300 x 70mm from Thermo Scientific
Biology Products: